Skip to main content

Case Comprehensive Cancer Center

head-neck-main
Hero Type
Image
Helping cancer patients avoid excessive radiation
Case Western Reserve-led research team identifies biomarker to identify which patients with oropharyngeal cancer will benefit from therapy ‘de-escalation’ A Case Western Reserve University-led team of scientists has used artificial intelligence (AI) to identify which patients with certain head and ...
lung-imaging
Hero Type
Image
Artificial intelligence tool predicts treatment response and survival in small cell lung cancer patients
Researchers identify set of patterns from CT scans to help predict patient’s response to chemotherapy Researchers at the Center for Computational Imaging and Personalized Diagnostics (CCIPD) at Case Western Reserve University have used artificial intelligence (AI) to identify patterns on computed t...
blanton-tolbert
Hero Type
Image
Blanton Tolbert appointed first associate director for diversity, equity and inclusion for the Case Comprehensive Cancer Center
Blanton S. Tolbert, vice dean for diversity, equity and inclusive excellence for Case Western Reserve School of Medicine, was recently appointed as the first associate director for diversity, equity and inclusion for the Case Comprehensive Cancer Center. The newly created associate director role a...
Annual Report to the Nation Part 2: Patient economic burden of cancer care more than $21 billion in the United States in 2019
Part 2 of the latest Annual Report to the Nation on the Status of Cancer finds that cancer patients in the United States shoulder a large amount of cancer care costs. In 2019, the national patient economic burden associated with cancer care was $21.09 billion, made up of patient out-of-pocket costs ...
Drupal-Aside-Photo.png
Hero Type
Image
Lucid Diagnostics Completes $70 Million Initial Public Offering
Company’s esophageal cancer prevention tests developed jointly by Case Comprehensive Cancer Center members, medical school faculty at Case Western Reserve University and University Hospitals Lucid Diagnostics Inc., a company that produces esophageal cancer tests based on Case Western Reserve Unive...
DSC_5627
Hero Type
Image
Campus Spotlight: Great Lakes Breast Cancer Symposium
October is Breast Cancer Awareness Month—an ideal time to join the Case Comprehensive Cancer Center for its annual Great Lakes Breast Cancer Symposium, to be held virtually Oct. 25-26. The event will highlight ongoing basic, translational, clinical and population studies addressing the biological m...
lucid-diagnostics-feat-1
Hero Type
Image
Lucid Diagnostics completes $70 million initial public offering
Company’s esophageal cancer prevention tests developed jointly by medical school faculty at Case Western Reserve University and University Hospitals Lucid Diagnostics Inc., a company that produces esophageal cancer tests based on Case Western Reserve University and University Hospitals research, h...
Tolbert-2019.jpeg
Hero Type
Image
Blanton Tolbert appointed first Associate Director for Diversity, Equity and Inclusion
The Case Comprehensive Cancer Center is pleased to announce the appointment of Blanton S. Tolbert, PhD as the first Associate Director for Diversity, Equity and Inclusion for the Case Comprehensive Cancer Center (Case CCC). This role will complement his recent appointment as Vice Dean for Diversity,...
Keri and Eng to lead new Cleveland Clinic Breast Cancer Center of Excellence
The center will support a multi-investigator research team focused on discerning the role of the tumor microenvironment in breast cancer progression. Ruth Keri, PhD, staff in the Department of Cancer Biology and associate director for basic research at the Case Comprehensive Cancer Center, and Char...
Computational Biologist Ming Hu Receives $2.4M NIH Genomic Innovator Award
The National Human Genome Research Institute (NHGRI) has awarded Department of Quantitative Health Sciences researcher Ming Hu, PhD, a five-year, $2.4 million grant to study how chromatin is organized within cells and its implications for human health and disease. The grant is part of NHGRI’s Genom...